Category: ImagingSyndicate content

Imaging

Boston Scientific aims to simplify intravascular imaging with Polaris

July 22, 2014 by Arezu Sarvestani

The Massachusetts medtech giant launches commercial efforts for its Polaris imaging software, an upgrade to the iLab system that aims to be "smart, fast and accurate."

Boston Scientific aims to simplify intravascular imaging with Polaris

Boston Scientific (NYSE:BSX) today announced the commercial launch of its Polaris imaging software, an upgrade to the company's iLab system that aims to make intravascular imaging simpler and more powerful.

DICOM Grid raises $6M for cloud-based medical imaging systems

July 18, 2014 by Arezu Sarvestani

DICOM Grid touts $6 million raised in an inside funding round in support of the company's cloud-based medical imaging management and exchange platform.

DICOM Grids raises $6M for cloud-based imaging management

Vermont medical imaging services provider DICOM Grid today announced that it raised $6 million in an inside funding round, with investment coming from Canaan Partners, CHL Medical Partners, the Mayo Clinic and several individual investors.

Veran Medical nears close of $7.5M round in support of airway imaging

July 8, 2014 by Arezu Sarvestani

Veran Medical is on a fundraising spree, adding another $6.5 million to its coffers in a $7.5 million round launches late last year.

Veran Medical nears close of $7.5M round in support of airway imaging

Veran Medical Technologies is on the verge of closing yet another fundraising round in support of its electromagnetic airway mapping system, with just about $1 million to go.

Dune Medical secures $14M for breast cancer detection

June 26, 2014 by Arezu Sarvestani

Dune Medical aims to boost its sales & marketing efforts with $21 million in equity financing that it hopes to raise before October.

Dune Medical secures $21M for breast cancer detection

Israeli imaging systems maker Dune Medical Devices touted the successful raise of $14 million in equity financing, looking to secure another $7 million before October to support its commercialization efforts.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Lantheus Medical plots IPO worth up to $125M

June 25, 2014 by Arezu Sarvestani

Lantheus Medical files registration forms ahead of an initial public offering worth up to $125 million in support of its diagnostic and imaging products.

Lantheus Medical plots IPO worth up to $125M

Massachusetts-based Lantheus Medical Imaging announced today that it filed registration documents ahead of launching an initial public offering.

The company, which makes imaging agents and other diagnostic products, has yet to reveal share pricing or quantity, but set the maximum aggregate offering price at $125 million. Lantheus deals primarily in radiopharmaceutical and contrast agents, according to the prospectus summary.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Press Release: FDA approves Lymphoseek to help determine the extent of head and neck cancer in the body

June 13, 2014 by MassDevice

Press Release: FDA approves Lymphoseek to help determine the extent of head and neck cancer in the body

The U.S. Food and Drug Administration today approved a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent used to help doctors determine the extent a type of cancer called squamous cell carcinoma has spread in the body's head and neck region.

FDA expands approval for Navidea's Lymphoseek for head and neck cancers

June 13, 2014 by Arezu Sarvestani

Ohio-based Navidea Biopharmaceuticals lands expanded FDA approval to market its Lymphoseek imaging agent for use in patients with cancers in the head and neck.

FDA expands approval for Navidea's Lymphoseek to head and neck

Navidea Biopharmaceuticals landed FDA approval to expand use for its Lymphoseek imaging agent to help track cancers spreading in the head and neck.

Lymphoseek is the "1st and only FDA-approved radiopharmaceutical application for sentinel lymph node detection," according to Navidea, which originally won FDA approval for Lymphoseek in March 2013.  

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp